Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Fabien Calvo

Showing results (1-10 of 85) with videos related to

Pageof 9
Sort By:
Medecine Sciences : M/S|April 14, 2009
[Colorectal cancer]Fabien Calvo
Recent Patents on Anti-Cancer Drug Discovery|January 20, 2009
The potential anti-tumorigenic and anti-metastatic side of the proprotein convertases inhibitorsRachid Lahlil, Fabien Calvo, Abdel-Majid Khatib
Nature Reviews. Clinical Oncology|July 11, 2012
Tumour molecular profiling for deciding therapy-the French initiativeFrédérique Nowak, Jean-Charles Soria, Fabien Calvo
Molecular Oncology|May 3, 2022
Ageing and cancer: a research gap to fillEric Solary, Nancy Abou-Zeid, Fabien Calvo
American Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting|May 30, 2013
Europe does it better: molecular testing across a national health care system-the French exampleFrédérique Nowak, Fabien Calvo, Jean-Charles Soria
Methods in Molecular Biology (Clifton, N.J.)|August 2, 2011
Identification of the myosin heavy polypeptide 9 as a downstream effector of the proprotein convertases in the human colon carcinoma HT-29 cellsNathalie Scamuffa, Peter Metrakos, Fabien Calvo, et al.
Medicinal Research Reviews|October 5, 2006
Potential opportunity in the development of new therapeutic agents based on endogenous and exogenous inhibitors of the proprotein convertasesYannick Bontemps, Nathalie Scamuffa, Fabien Calvo, et al.
Medicinal Chemistry (Shariqah (United Arab Emirates))|March 14, 2008
Inhibitory feature of the proprotein convertases prosegmentsYannick Bontemps, Marion Lapierre, Geraldine Siegfried, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 17, 2012
Biomarker discovery, development, and implementation in France: a report from the French National Cancer Institute and cooperative groupsFabrice Andre, Frederique Nowak, Monica Arnedos, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|October 3, 2006
Proprotein convertases: lessons from knockoutsNathalie Scamuffa, Fabien Calvo, Michel Chrétien, et al.
Pageof 9

Showing results (1-10 of 85) with videos related to

Sort By:
Pageof 9
Medecine Sciences : M/S|April 14, 2009
[Colorectal cancer]Fabien Calvo
Recent Patents on Anti-Cancer Drug Discovery|January 20, 2009
The potential anti-tumorigenic and anti-metastatic side of the proprotein convertases inhibitorsRachid Lahlil, Fabien Calvo, Abdel-Majid Khatib
Nature Reviews. Clinical Oncology|July 11, 2012
Tumour molecular profiling for deciding therapy-the French initiativeFrédérique Nowak, Jean-Charles Soria, Fabien Calvo
Molecular Oncology|May 3, 2022
Ageing and cancer: a research gap to fillEric Solary, Nancy Abou-Zeid, Fabien Calvo
American Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting|May 30, 2013
Europe does it better: molecular testing across a national health care system-the French exampleFrédérique Nowak, Fabien Calvo, Jean-Charles Soria
Methods in Molecular Biology (Clifton, N.J.)|August 2, 2011
Identification of the myosin heavy polypeptide 9 as a downstream effector of the proprotein convertases in the human colon carcinoma HT-29 cellsNathalie Scamuffa, Peter Metrakos, Fabien Calvo, et al.
Medicinal Research Reviews|October 5, 2006
Potential opportunity in the development of new therapeutic agents based on endogenous and exogenous inhibitors of the proprotein convertasesYannick Bontemps, Nathalie Scamuffa, Fabien Calvo, et al.
Medicinal Chemistry (Shariqah (United Arab Emirates))|March 14, 2008
Inhibitory feature of the proprotein convertases prosegmentsYannick Bontemps, Marion Lapierre, Geraldine Siegfried, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 17, 2012
Biomarker discovery, development, and implementation in France: a report from the French National Cancer Institute and cooperative groupsFabrice Andre, Frederique Nowak, Monica Arnedos, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|October 3, 2006
Proprotein convertases: lessons from knockoutsNathalie Scamuffa, Fabien Calvo, Michel Chrétien, et al.
Pageof 9